FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures NDI warning letters fuel criticism of FDA enforcement approach The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Dietary Supplement Enforcement Trends What is FDA looking for? Eurofins USA